Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBITDA Margin (2020 - 2025)

Sotera Health (SHC) has 6 years of EBITDA Margin data on record, last reported at 16.65% in Q4 2025.

  • For Q4 2025, EBITDA Margin rose 4122.0% year-over-year to 16.65%; the TTM value through Dec 2025 reached 15.16%, up 2162.0%, while the annual FY2025 figure was 15.16%, 2162.0% up from the prior year.
  • EBITDA Margin reached 16.65% in Q4 2025 per SHC's latest filing, up from 10.02% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 30.28% in Q2 2025 and bottomed at 104.29% in Q4 2022.
  • Average EBITDA Margin over 5 years is 0.37%, with a median of 2.86% recorded in 2021.
  • Peak YoY movement for EBITDA Margin: tumbled -12871bps in 2022, then soared 12367bps in 2023.
  • A 5-year view of EBITDA Margin shows it stood at 24.42% in 2021, then crashed by -527bps to 104.29% in 2022, then surged by 119bps to 19.38% in 2023, then plummeted by -227bps to 24.57% in 2024, then soared by 168bps to 16.65% in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA Margin were 16.65% in Q4 2025, 10.02% in Q3 2025, and 30.28% in Q2 2025.